CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Congenital Abnormalities D000013 11 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anemia D000740 21 associated lipids
Arteriosclerosis D001161 86 associated lipids
Asthma D001249 52 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Birth Weight D001724 23 associated lipids
Body Weight D001835 333 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Pinkofsky HB and Jung CY Accessibility of sulfhydryl residues induced by cytochalasin B binding and conformational dynamics in the human erythrocyte glucose transporter. 1985 Arch. Biochem. Biophys. pmid:4040351
May JM and Qu ZC Chelation of intracellular iron enhances endothelial barrier function: a role for vitamin C? 2010 Arch. Biochem. Biophys. pmid:20510668
Yamashita T et al. Response of superoxide anion production by guinea pig eosinophils to various soluble stimuli: comparison to neutrophils. 1985 Arch. Biochem. Biophys. pmid:2994568
Walters SN et al. Intracellular location of unoccupied 1,25-dihydroxyvitamin D receptors: a nuclear-cytoplasmic equilibrium. 1986 Arch. Biochem. Biophys. pmid:3008657
Klip A and Walker D The glucose transport system of muscle plasma membranes: characterization by means of [3H]cytochalasin B binding. 1983 Arch. Biochem. Biophys. pmid:6681949
Madsen K Glycosaminoglycan secretion from perifused monolayer cultures of rabbit ear chondrocytes: modification of xyloside effect by colchicine and cytochalasin B. 1981 Arch. Biochem. Biophys. pmid:7305375
Anthes JC et al. Sequential degradation of choline phosphoglycerides by phospholipase D and phosphatidate phosphohydrolase in dibutyryl cAMP-differentiated U937 cells. 1991 Arch. Biochem. Biophys. pmid:1654804
Klip A et al. Identification of the glucose transporter in rat skeletal muscle. 1983 Arch. Biochem. Biophys. pmid:6685458
Haworth RA et al. Heterogeneous response of isolated adult rat heart cells to insulin. 1984 Arch. Biochem. Biophys. pmid:6380412
Patel NA et al. Phosphoinositide 3-kinase mediates protein kinase C beta II mRNA destabilization in rat A10 smooth muscle cell cultures exposed to high glucose. 2002 Arch. Biochem. Biophys. pmid:12061808
Ryals PE and Kersting MC Sodium-dependent uptake of [3H]scyllo-inositol by Tetrahymena: incorporation into phosphatidylinositol, phosphatidylinositol-linked glycans, and polyphosphoinositols. 1999 Arch. Biochem. Biophys. pmid:10356291
Grinnell F Studies on the mechanism of cell attachment to a substratum with serum in the medium: further evidence supporting a requirement for two biochemically distinct processes. 1974 Arch. Biochem. Biophys. pmid:4474838
Nakae D et al. Endocytosis-independent uptake of liposome-encapsulated superoxide dismutase prevents the killing of cultured hepatocytes by tert-butyl hydroperoxide. 1990 Arch. Biochem. Biophys. pmid:2350179
McCormick JI and Johnstone RM Asymmetric reconstitution of the glucose transporter from Ehrlich ascites cell plasma membrane: role of alkali cations. 1986 Arch. Biochem. Biophys. pmid:3729423
Szarka A et al. Facilitated glucose and dehydroascorbate transport in plant mitochondria. 2004 Arch. Biochem. Biophys. pmid:15234271
Walling EA et al. Actin assembly activity of cytochalasins and cytochalasin analogs assayed using fluorescence photobleaching recovery. 1988 Arch. Biochem. Biophys. pmid:3395126
Solomkin JS et al. Regulation of neutrophil superoxide production in sepsis. 1985 Arch Surg pmid:2981524
Gimenéz-Scherer A et al. [Ultrastructural changes associated with the inhibition of human monocyte chemotaxis caused by products of E. histolytica cultured in axenic medium]. 1986 Arch Invest Med (Mex) pmid:2884964
Arruda JA et al. Effect of agents that alter cell calcium and microfilaments on CO2 stimulated H+ secretion in the turtle bladder. 1988 May-Jun Arch Int Pharmacodyn Ther pmid:3138952
Franke H and Estel C [Studies on the ultrastructure and permeability of the term amnion with special reference to the microfilamentous and microtubular structures (author's transl)]. 1978 Arch Gynakol pmid:581444
García-Valdecasas JC et al. [Pharmacological reactivity of myofibroblasts in granulation tissue]. 1981 Arch Farmacol Toxicol pmid:7325700
Lievens A et al. Morphology and X-ray sensitivity of rat glial cells after cytochalasin B treatment. 1974 Arch Biol (Liege) pmid:4371052
Ruch JV et al. [Effects of cytochalasin B and colchicine on dental cytodifferentiation in vitro]. 1975 Apr-Jun Arch Anat Microsc Morphol Exp pmid:1217902
Sompolinsky D and Richmond S Growth of Chlamydia trachomatis in McCoy cells treated with cytochalasin B. 1974 Appl Microbiol pmid:4451373
Esposito AL et al. An assessment of the factors contributing to the killing of type 3 Streptococcus pneumoniae by human polymorphonuclear leukocytes in vitro. 1990 APMIS pmid:2405890
Lock R and Dahlgren C Characteristics of the granulocyte chemiluminescence reaction following an interaction between human neutrophils and Salmonella typhimurium bacteria. 1988 APMIS pmid:3285865
Henderson PJ et al. Dissection of discrete kinetic events in the binding of antibiotics and substrates to the galactose-H+ symport protein, GalP, of Escherichia coli. 1994 Antonie Van Leeuwenhoek pmid:7832591
Walters JD et al. Mechanisms of fluoroquinolone transport by human neutrophils. 1999 Antimicrob. Agents Chemother. pmid:10543751
Okuda K Effects of cytochalasin B on the intrcellular bactericidal activity of human neutrophils. 1975 Antimicrob. Agents Chemother. pmid:1155917
Mandell LA and Afnan M Mechanisms of interaction among subinhibitory concentrations of antibiotics, human polymorphonuclear neutrophils, and gram-negative bacilli. 1991 Antimicrob. Agents Chemother. pmid:1929284
Trendowski M et al. The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells. 2014 Anticancer Res. pmid:24778021
Baatout S et al. Inhibition of actin polymerization by cytochalasin B induces polyploidization and increases the number of nucleolar organizer regions in human megakaryocyte cell lines. 1998 Jan-Feb Anticancer Res. pmid:9568120
Trendowski M et al. Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents. 2015 Anticancer Res. pmid:25550536
Baatout S et al. Interaction between protein kinase C and actin in megakaryocyte polyploidization. 1999 Sep-Oct Anticancer Res. pmid:10628374
Aston R and Ayad SR Cyclic AMP mediated morphological changes in a hybrid cell line. 1981 Anticancer Res. pmid:6287905
Bracke ME et al. Action mechanisms of anti-invasive agents. 1986 Nov-Dec Anticancer Res. pmid:3813483
Castiglione S et al. Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions. 1993 Anticancer Drugs pmid:8358069
Feurer C and Borel JF Localised leukocyte moblisation in the rabbit ear. An in vivo cell migration technique using plastic collection chambers. 1974 Antibiot Chemother (1971) pmid:4463828
Samson FE Pharmacology of drugs that affect intracellular movement. 1976 Annu. Rev. Pharmacol. Toxicol. pmid:938015
Zimmerman TJ et al. Advances in ocular pharmacology. 1980 Annu. Rev. Pharmacol. Toxicol. pmid:6155823
Gu YJ et al. Increased neutrophil priming and sensitization before commencing cardiopulmonary bypass in cardiac surgical patients. 2002 Ann. Thorac. Surg. pmid:12400764
Dularay B et al. Oxidative response of polymorphonuclear leucocytes to synovial fluids from patients with rheumatoid arthritis. 1990 Ann. Rheum. Dis. pmid:2173500
Nurcombe HL et al. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo. 1991 Ann. Rheum. Dis. pmid:1849716
Crockford A et al. Cyclin D mediates tolerance of genome-doubling in cancers with functional p53. 2017 Ann. Oncol. pmid:28177473
Kalaria RN et al. The glucose transporter of the human brain and blood-brain barrier. 1988 Ann. Neurol. pmid:3207358
Malaisse WJ et al. Role of microtubules in the phasic pattern of insulin release. 1975 Ann. N. Y. Acad. Sci. pmid:1096725
Malawista SE Microtubules and the movement of melanin granules in frog dermal melanocytes. 1975 Ann. N. Y. Acad. Sci. pmid:1096728
Goetzl EJ Plasma and cell-derived inhibitors of human neutrophil chemotaxis. 1975 Ann. N. Y. Acad. Sci. pmid:1099960
Barnett RE and Palazzotto J Mechanism of the effects of lipid phase transitions on the Na+, K+-ATPase, and the role of protein conformational changes. 1974 Ann. N. Y. Acad. Sci. pmid:4372931
Harik SI and Kalaria RN Blood-brain barrier abnormalities in Alzheimer's disease. 1991 Ann. N. Y. Acad. Sci. pmid:1685645